by! The Herbal Working Group of the CAM Stakeholder Group !
Presenter: Robert Verkerk PhD - Alliance for Natural Health International!
Also on behalf of:
! EHTPA - European Herbal & Traditional Medicine Practitioners Association!
EITAM - European Initiative for Traditional Asian Medicine!

Use of herbals in the EU!

1st European Hearb Gathering

Market reports consistently show herbal medicine most popular form of complementary medicine used in Europe !
Germany and France = market leaders!

Herbal medicines widely used across the EU e.g. 2009 UK MHRA* showed that over a quarter of the UK population had used a herbal remedy in the previous 2 years !

Consumers relying on the legislators to provide them with a full range of traditional herbal medicines. Failure to achieve this will force consumers to buy from unreliable internet sources or back-street traders".

CAM-METHODS

Variety of Treatments

Today there are over eighty different complementary methods and alternative treatments. This also includes independent healing systems from different cultures and traditions. A common basis and unifying link throughout is holistic thinking.

PLANET HEALTH

For a Free and Healthy Europe

While the foundation for European legislation is under the control of the national states, together our states work to promote the free choice of therapy, choice of practitioner, and the option for self-care and self-help/improvement in both the public and private market.

ORGANIZATION

Who We Are and What We Do

As a European umbrella organization, ANME works on behalf of the common interests of citizens, patients, therapists, and manufacturers in the field of remedies and natural healing methods. We build capacity and raise awareness about the scope and versatility of and for natural medicine.

Pharmaceutical strategy for Europe

As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission published on 2nd of July a roadmap, inviting interested citizens and stakeholders to share their views on the Strategy. Scheduled to be adopted before the end of the year, the overall objective of the Pharmaceutical Strategy for Europe is to help ensure Europe's supply of safe and affordable medicines and support the European pharmaceutical industry to remain an innovator and world leader.

Stella Kyriakides, Commissioner in charge of Health & Food Safety, said:

“By the end of the year, I will present an ambitious Pharmaceutical Strategy for Europe to ensure affordability, sustainability and security of supply. The coronavirus pandemic has showed us more than ever that we need to have a crisis-resistant system and the means to produce medicine within the EU to ensure timely access to essential medicines for our citizens and hospitals in all circumstances.”

Citizens, experts and stakeholders are invited to give, until 7 July 2020, their feedback to the roadmap through the Better Regulation Portal and consult the dedicated website for additional information and to follow updates. This roadmap will be followed by a public consultation.

Read more here…